Daiichi Sankyo Starts Patient dosing in DESTINY-Lung04 Phase 3 trial of Enhertu
Summary : Daiichi Sankyo Company, Limited announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial evaluating the…
Summary : Daiichi Sankyo Company, Limited announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial evaluating the…
Summary : – Medikabazaar, an online B2B platform for medical supplies, is looking to achieve a gross merchandise value (GMV) of around…
Synopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the…
Synopsis: After a special meeting, the Japanese drug reviewers ruled that existing data didn’t support an approval and are therefore seeking additional…
Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
Synopsis : Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma…
Summary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…
Summary – BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced…
Synopsis : Company announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase…
Synopsis : BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the right relating to…